首页 | 本学科首页   官方微博 | 高级检索  
   检索      

错配修复蛋白hMSH2、hMLH1在涎腺粘液表皮样癌中的表达
引用本文:宋颖韬,周晓燕,孙长生,孟琰,赵尔飏.错配修复蛋白hMSH2、hMLH1在涎腺粘液表皮样癌中的表达[J].现代生物医学进展,2014,14(10):1839-1843.
作者姓名:宋颖韬  周晓燕  孙长生  孟琰  赵尔飏
作者单位:[1]哈尔滨医科大学附属第一医院口腔医院口腔修复科,黑龙江哈尔滨150001 [2]哈尔滨医科大学附属第二医院病理科,黑龙江哈尔滨150086 [3]哈尔滨医科大学口腔医学研究所,黑龙江哈尔滨150001 [4]哈尔滨医科大学口腔医学院口腔组织病理教研室,黑龙江哈尔滨150001
基金项目:黑龙江省自然科学基金项目(D201151)
摘    要:目的:探讨人类错配修复基因2 the human mutS homolog 2(hMSH2)人类错配修复基因1human mutL homolog 1(hMLH1)在涎腺粘液表皮样癌(salivary gland mucoepidermoid carcinoma-SMEC)表达水平及临床病理意义。重点研究人类错配修复基因2和人类错配修复基因1与目标肿瘤发生的相关性。方法:采用HE染色方法筛选共计47例典型病例,采用免疫组织化学染色分析37例SMEC、10例正常组织涎腺中hMSH2、hMLH1的表达水平,结合计算机辅助高清晰图像分析处理技术做出综合评价。结果:hMLH1的表达与SMEC分化呈负相关(P0.05);hMLH1的低表达或表达缺失在低分化的SMEC中较普遍,在中分化和高分化中表达逐步增强;hMSH2的表达与SMEC分化不相关(P0.05)。结论:hMSH2、hMLH1异常表达与涎腺黏液表皮样的发生、演进存在相关性,以hMLH1、hMSH2为切入点为涎腺黏液表皮样癌治疗与预防提供参考依据。

关 键 词:错配修复  hMSH2  hMLH1  涎腺  黏液表皮样癌  免疫组化染色  hMSH2  hMLH1

Expression of hMLH1, hMSH2 in Salivary Gland Mucoepidermoid Carcinoma*
SONG Ying-tao,ZHOU Xiao-yan,SUN Chang-sheng,MENG Yan,ZHAO Er-yang.Expression of hMLH1, hMSH2 in Salivary Gland Mucoepidermoid Carcinoma*[J].Progress in Modern Biomedicine,2014,14(10):1839-1843.
Authors:SONG Ying-tao  ZHOU Xiao-yan  SUN Chang-sheng  MENG Yan  ZHAO Er-yang
Institution:SONG Ying-tao, ZHOU Xiao-yan, SUN Chang-sheng, MENG Yan, ZHA O Er-yang (1 Department of Prosthodontics, lst Attiliated Hospital, School of Stomatology, Harbin Medical University, Harbin, Heilongjiang, 150001, China; 2 Department of Pathology, 2rid Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150086, China; 3 Institute of Stomatological Research, Harbin Medical University, Harbin ,Heilongfiang, 150001, China; 4 Department of Oral Patholoy, School of Stomatoloy, Harbin Medical University, Harbin, Heilongjiang, 150001, China)
Abstract:Objective: The aim of this study was to describe the human mutS homolog 2 (hMSH2) and human mutL homolog 1 (hMLH1) immunoexpression in different areas of salivary gland mucoepidermoid carcinoma in an attempt to verify if the histological grade of malignancy interferes in this expression. The research emphasis is whether hMSH2, hMLH1 correlate with target carcinoma. Methods: Tissues in 37 cases with mucoepidermoid carcinoma and 10 normal salivary gland were determined by HE staining and the ex- pression of hMLH1, hMSH2 were tested using computer-assised high-resolution image analysis and processing techniques. Results: The hMHL 1 immunoexpression was negatively correlated with histological grades of malignancy(P〈0.05 ); hMHL 1 reduction or negative ex- pression was detected in poorly differentiated tumors, but the expression gradually enhanced in moderately differentiated and well differ- entiated tumors. The hMSH2 immunoexpression was not correlated with histological grades of malignancy, whereas hMLH1 overexpres- sion was correlated and associated (P〉0.05) with histological grades of malignancy. Conclusion: The anomalo expression of hMLH1, hMSH2 get the relationship with the occurrence and development of slivary gland mucoepidermoid carcinoma. We can use hMLH1, hMSH2 as a point to incisivus in slivary gland tumour, and they have graveness significance on the precaution and therapy to slivary gland mucoepidermoid carcinoma.
Keywords:Mismatch repair  hMSH2  hMLH1  Salivary gland  Mucoepidermoid carcinoma  Immunohistochemistry
本文献已被 CNKI 维普 等数据库收录!
点击此处可从《现代生物医学进展》浏览原始摘要信息
点击此处可从《现代生物医学进展》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号